Concepedia

Thomas B. Hakes

TB

Statistics

Publications

60

Citations

3.9K

H-Index

33

Active since

1979

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Thomas B. Hakes is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and chemotherapy.

Publications per year

1979–1995

60

Publications

60

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 854 citations

, , +13

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Maurie Markman, Eric K. Rowinsky, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1992 · 314 citations

, , +17

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

Maurie Markman, Bonnie Reichman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 190 citations

, , +14

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

Thomas B. Hakes, Eva Chalas, W.J. Hoskins et al. · Gynecologic Oncology · 1992 · 166 citations

, , +13

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

M Markman, Thomas B. Hakes, Bonnie Reichman et al. · Journal of Clinical Oncology · 1992 · 135 citations

, , +15

1–5 of 60